Non-Hodgkin lymphoma Posts on Medivizor
Navigation Menu

Non-Hodgkin lymphoma Posts on Medivizor

What are the long-term effects in adult survivors of childhood non-Hodgkin lymphoma?

Posted by on Jun 14, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study explored the long-term health outcomes of adult survivors of childhood non-Hodgkin lymphoma (NHL) patients. The authors determined that adult survivors have a high rate of chronic health conditions. Some background Long-term survival of childhood NHL has increased due to improvements in treatment options. An understanding...

Read More

Stem cell transplantation in follicular lymphoma

Posted by on Jun 14, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study reviewed the use of stem cell (immature blood cell) transplantation in follicular lymphoma. Some background New treatment options have improved survival in follicular lymphoma patients. Improvements in stem cell transplantation (SCT) have also led to increased survival. Typically only younger patients have been able to...

Read More

Combining bendamustine and rituximab improves time to disease progression in follicular and mantle-cell lymphomas

Posted by on Jun 14, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the use of the combination of bendamustine (Treanda) and rituximab (Rituxan) as a firstline treatment in patients with follicular or mantle cell lymphoma. This study concluded that this treatment combination was more effective than the standard treatment of rituximab plus CHOP chemotherapy. Some background The...

Read More

Is ibrutinib effective as a first-line therapy in B-cell non-Hodgkin lymphoma?

Posted by on Jun 14, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the use of ibrutinib (Imbruvica) combined with the chemotherapy combination R-CHOP in untreated diffuse large B-cell lymphoma. This study determined that ibrutinib was safe and effective when added to R-CHOP. Some background R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) is a...

Read More

Predicting outcome in mantle cell lymphoma

Posted by on Jun 6, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study developed a method of predicting prognosis for patients with advanced mantle cell lymphoma (MCL). The authors concluded that the MCL International Prognostic Index (MIPI) was more accurate for MCL compared to those developed for other types of lymphoma. Some background Mantle cell lymphoma (MCL) is an uncommon form of...

Read More

Long-term effectiveness of immunochemotherapy and stem cell transplantation in mantle cell lymphoma

Posted by on Jun 4, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study reported on the long-term outcome of intensive immunochemotherapy and stem cell transplantation in patients with mantle cell lymphoma. This study concluded that long-term results were encouraging but highlighted the need for personalized treatment options. Some background The combination of intensive chemotherapy combined...

Read More

Adding rituximab to the chemotherapies CHOP and DHAP before stem cell transplantation

Posted by on Jun 3, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the effectiveness of adding rituximab (Rituxan) to chemotherapy combinations. This study concluded that this combination was safe and effective in mantle cell lymphoma. Some background There is no standard treatment for newly diagnosed younger (less than 65) patients with mantle cell lymphoma. Cytarabine-based...

Read More

Predicting outcomes in follicular lymphoma

Posted by on Jun 3, 2017 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the development of a prognostic score that could help in predicting patient outcome in follicular lymphoma (FL). This study determined that the FL International Prognostic Index they developed could be useful in choosing treatments and predicting outcome.  Some background Follicular lymphoma is an indolent...

Read More